Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Click here to view
our current issue


RNAi-based Therapeutics: Promises and Challenges

The field of antisense-mediated control of gene expression is nearing the end of its third decade, and finally looks to have matured enough to start realising some of its much-heralded potential.

Dr Mohammed Amarzguioui, siRNAsense AS (April 2006)

Keywords: antisense-mediated control gene expression potential

    View full article    |    Back to Biopharma section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |